2'-fluorophosphophloretinAlternative Names: 2FP
Latest Information Update: 04 Aug 2016
At a glance
- Originator DuoPhos
- Class Small molecules
- Mechanism of Action Sodium-phosphate cotransporter protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Renal failure
Most Recent Events
- 04 Aug 2016 Discontinued - Preclinical for Renal failure in USA (PO)